The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
about
MicroRNA biogenesis and their functions in regulating stem cell potency and differentiationExpression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomesCisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway.Resistance to Cell Death and Its Modulation in Cancer Stem Cells.The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.MicroRNA-targeted therapeutics for lung cancer treatment.Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo[3,2-a]benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation.Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung CancerCBP501 suppresses macrophage induced cancer stem cell like features and metastases.NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro.Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.The combination of curcumin and 5-fluorouracil in cancer therapy.Access to Lung Cancer Screening Services: Preliminary Analysis of Geographic Service Distribution Using the ACR Lung Cancer Screening Registry.Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins.Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Q26766383-A69AE0D0-0F2A-410A-B9DA-A582E08A3EE8Q33709741-7C4A4A3A-2074-4934-9752-28E351DC8420Q33815839-03E2CDCF-636D-4419-8516-59B6785B17E4Q33829653-93ED15C0-F4D6-405E-B4DA-8CFE7BD0A582Q37427658-DF72C568-FF47-46DD-BB3D-A4D47FA44C03Q37708637-1012F0BE-BBC1-4DAC-BB4A-F415890DE3A8Q37745486-4C97BD8E-812C-466B-9F97-6104D6B5615DQ38598784-76D35FB3-C111-4412-95C8-477EB4D05D06Q38784131-12BC8AAB-F816-4235-8CE2-3CA28C9E491BQ39014580-17C654B6-02AA-4FB7-BD7C-80E2127BFF1FQ40126891-EDC2D2F2-46A1-4210-828F-405A2829652AQ41552614-EDA812B8-206A-486A-A5F6-C91BD466C145Q41873851-7B18E453-8FFF-4DF2-9219-69C42ACEFD65Q42364472-401BF6CF-F70E-4E94-9D2A-7607793FF178Q47093759-6826B6D9-F704-466F-BDE2-AF26D6E63428Q47101870-20D437D9-968E-4A69-B630-A8D480523DB4Q47577912-9B295BA5-7D4F-42C2-A403-2A1EC597D1D2Q47659806-D1079659-8B9C-416F-9D4E-8BFE858E3844Q47790409-10B56B88-5BEE-45B5-B5FE-A2CFABE5C560Q55260649-8765D8E9-7E28-4D2C-A5CD-A1101D53D978Q57174410-DBAA85FC-A9CB-4BC5-A91F-A0DC091F5604
P2860
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
@en
type
label
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
@en
prefLabel
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
@en
P2093
P1476
The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
@en
P2093
Aamir Ahmad
Fazlul H Sarkar
Philip A Philip
Raagini Suresh
Shadan Ali
P356
10.1007/978-3-319-24932-2_4
P407
P577
2016-01-01T00:00:00Z